Seattle Genetics (SGEN - Get Report) is a biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for cancer. This stock is trading up 2.5% at $20.82 in recent trading.
Today's Volume: 1.8 millionAverage Volume: 1.1 million Volume % Change: 198% From a technical perspective, SGEN exploded higher in earlier trading and even triggered a breakout move above some near-term overhead resistance at $21.04 with monster volume. At last check, SGEN has pulled back off its intraday high of $21.99 to its current price around $20.80. Traders should now only look for long-biased trades if SGEN is trending above $21.04 and today's high of $21.99 with strong upside volume flows. I would consider any volume that's near or above 1.1 million shares as bullish. If we get that action, look for SGEN to re-test its 2011 high of $22.40 in the near future. I also featured Seattle Genetics recently in " 5 Stocks Set to Soar on Bullish Earnings."
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts